Oct 2 (Reuters) – HKEX : * UBS GROUP AG'S LONG POSITION IN H-SHARES OF JIANGSU HENGRUI PHARMACEUTICALS DECREASES TO 4.59% ON SEPT 25 FROM 5.17% – HKEX Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Leila Miller BUENOS AIRES, Oct 2 (Reuters) - Buenos Aires is hosting its first…
(Adds comments on sugar, updates prices to settlement) LONDON, Oct 2 (Reuters) - Raw sugar…
By Anzar Mehraj Oct 2 (Reuters) - Paramount Skydance CEO David Ellison on Friday said…
* Futures imply about a 25% chance of October hike after jobs data * September…
VIDEO SHOWS: EXTERIORS OF MANCHESTER CITY’S ETIHAD STADIUM/ ARCHIVE VIDEO OF HIS MAJESTY'S REVENUE AND CUSTOMS…
By Kate Abnett and Jarrett Renshaw BRUSSELS, Oct 2 (Reuters) - Group of Seven countries…